Compare · MGRX vs SHC
MGRX vs SHC
Side-by-side comparison of Mangoceuticals Inc. (MGRX) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MGRX and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC carries a market cap of $5.88B.
- SHC has hit the wire 4 times in the past 4 weeks while MGRX has been quiet.
- SHC has more recent analyst coverage (25 ratings vs 0 for MGRX).
- Company
- Mangoceuticals Inc.
- Sotera Health Company
- Price
- $0.43+8.01%
- $15.59+1.63%
- Market cap
- -
- $5.88B
- 1M return
- -
- +13.80%
- 1Y return
- -
- +38.45%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2020
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 25
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest MGRX
- SEC Form 10-K filed by Mangoceuticals Inc.
- SEC Form NT 10-K filed by Mangoceuticals Inc.
- SEC Form 4 filed by Cohen Jacob D.
- SEC Form 4 filed by Cohen Jacob D.
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
- Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Latest SHC
- Sotera Health Announces First-Quarter 2026 Earnings Release Date
- SEC Form DEFA14A filed by Sotera Health Company
- SEC Form DEF 14A filed by Sotera Health Company
- SEC Form 3 filed by new insider Ostrowski Erika
- SEC Form 4 filed by Dimitrief Alexander
- Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company
- SEC Form 3 filed by new insider Krause Kenneth D.
- Sotera Health Company filed SEC Form 8-K: Leadership Update
- Sotera Health Appoints Kenneth D. Krause to the Board of Directors
- Director Warburg Pincus & Co. sold $229,050,000 worth of shares (15,000,000 units at $15.27) (SEC Form 4)